ABIOMED Financials
Based on the measurements of operating efficiency obtained from ABIOMED's historical financial statements, ABIOMED is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.
ABIOMED |
Understanding current and past ABIOMED Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABIOMED's financial statements are interrelated, with each one affecting the others. For example, an increase in ABIOMED's assets may result in an increase in income on the income statement.
Please note, the presentation of ABIOMED's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIOMED's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABIOMED's management manipulating its earnings.
ABIOMED Stock Summary
ABIOMED competes with Nabors Industries, Tenaris SA, AKITA Drilling, Xunlei, and Awilco Drilling. Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US0036541003 |
| Business Address | 22 Cherry Hill |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abiomed.com |
| Phone | 978 777 8411 |
| Currency | USD - US Dollar |
ABIOMED Key Financial Ratios
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Target Price | 363.0 | |||
| Beta | 1.4 |
ABIOMED Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABIOMED's current stock value. Our valuation model uses many indicators to compare ABIOMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIOMED competition to find correlations between indicators driving ABIOMED's intrinsic value. More Info.ABIOMED is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ABIOMED is roughly 1.91 . Comparative valuation analysis is a catch-all technique that is used if you cannot value ABIOMED by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.ABIOMED Market Pulse
| Quote | 0.0 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 0.0 |
| Low | 0.0 |
| High | 0.0 |
| Volume | 1 |
| Exchange | NASDAQ |
About ABIOMED Financials
What exactly are ABIOMED Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ABIOMED's income statement, its balance sheet, and the statement of cash flows. Potential ABIOMED investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ABIOMED investors may use each financial statement separately, they are all related. The changes in ABIOMED's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ABIOMED's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.ABIOMED Thematic Clasifications
ABIOMED is part of several thematic ideas from Obamacare Repeal to Obamacare. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |